• US Stocks
  • AbbVie Inc.
AbbVie Inc.

AbbVie Inc.

ABBV
HealthcareLarge Cap 
  • $ 143.12

    Stock Price

  • -$ 1.03(-0.71%)

    Last Change

About the company

AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C. It also provides Kaletra, an anti- human immunodeficiency virus(HIV)-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, endometriosis, and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product for human use; and ZINBRYTA, a subcutaneous treatment for relapsing forms of multiple sclerosis. The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has collaboration agreements with C2N Diagnostics; Calico Life Sciences LLC; Infinity Pharmaceuticals, Inc.; and M2Gen. The company was incorporated in 2012 and is based in North Chicago, Illinois.
View More
    Total Revenue
    $ 14.583 B
    Cost of Revenue
    $ 4.170 B
    Gross Profit
    $ 10.413 B
    Operating Income
    $ 3.392 B
Scripbox Recommended US Equity Funds
Want to get exposure to US Equity with the ease of Mutual Funds?Learn more

Price chart

$ 144.16

1D High

$ 143.20

1D Low

-$ 1.03 (-0.71%)

1D Change

Last updated on 

Previous Close
$ 144.15
Open Price
$ 144.11
52 Week High
$ 162.75
52 Week Low
$ 128.24
PE Ratio
39.21
Volume
293,342
Avg. Volume
5,372,416
Market Cap
$ 252.684 B
peers

Peers

Stock NameStock Price52 Week High52 Week LowCapital
AstraZeneca PLC
AstraZeneca PLC
$ 66.57$ 71.09$ 51.90Large Cap
$ 236.76$ 292.06$ 219.83Large Cap
$ 56.28$ 78.63$ 55.70Large Cap
$ 110.41$ 129.29$ 89.04Large Cap
$ 39.75$ 43.84$ 32.35Large Cap
$ 66.77$ 86.09$ 65.90Large Cap
$ 261.22$ 311.88$ 187.16Large Cap
$ 32.34$ 53.25$ 31.77Large Cap
$ 726.02$ 800.78$ 367.60Large Cap
peers

Frequently Asked Questions

What is the price of AbbVie Inc. share today in India?

Today, on 21st Apr 2024, the price of AbbVie Inc. Shares in India is $ 143.12.

What was the highest AbbVie Inc. share stock price?

The highest AbbVie Inc. stock price was $ 162.75 till 21st Apr 2024 within the past 52 weeks.

What is the lowest price of ABBV shares?

The lowest ABBV stock price was $ 128.24 on 21st Apr 2024 within the past 52 weeks.

How to buy ABBV shares in India?

You can buy ABBV shares in India through Scripbox in just 4 simple steps. The process is simple, seamless, and paperless.
  • Create an account and submit KYC documents
  • On successful KYC, transfer amount required for investment
  • Invest in US stocks
  • Track and manage investments through Scripbox dashboard

Is AbbVie Inc. shares Listed on NSE or BSE?

No, ABBV shares are not listed on NSE or BSE. AbbVie Inc. is listed on the NASDAQ stock exchange.

Can I buy AbbVie Inc. shares in India?

Yes, you can buy AbbVie Inc. shares in India by simply opening an account with Scripbox.

Can I buy fractional shares of AbbVie Inc.?

Yes, you can buy fractional shares of AbbVie Inc. with Scripbox.

What is the P/E ratio for AbbVie Inc. shares?

As on 21st Apr 2024, the P/E ratio for AbbVie Inc. shares is 39.21.

What is the traded volume of AbbVie Inc. shares?

As on 21st Apr 2024, the traded volume for AbbVie Inc. shares is 293.342 undefined.

What is the market capitalization of AbbVie Inc. shares?

AbbVie Inc. shares has a market capitalization of $ 252.684 B.